Replies to post #31404 on Intellipharmaceutics International Inc. (IPCI)

[fred198484]

Thought you might like to see the breakdown in sales according to strength. This is the number of prescriptions for each strength - you can see having the 5mg version might help.


Bloomberg Intelligence: Molecule Detail
Molecule DEXMETHYLPHENIDATE HCL

View TRX Count By Strength By Month

Strength 10/31/2017 09/30/2017 08/31/2017 07/31/2017 06/30/2017 05/31/2017 04

Total 368.16k 340.36k 347.85k 270.23k 290.80k 355.92k
10MG 109.19k 102.14k 105.30k 80.43k 86.17k 105.36k
5MG 68.97k 63.06k 64.85k 47.22k 50.93k 64.55k
20MG 57.93k 53.49k 54.77k 43.48k 46.86k 56.94k
15MG 55.70k 50.70k 51.09k 38.91k 42.52k 54.21k
30MG 30.95k 29.06k 29.65k 25.37k 27.19k 31.52k
25MG 19.00k 17.25k 17.22k 14.01k 14.95k 17.94k
40MG 13.81k 13.03k 13.40k 11.92k 12.60k 13.83k
2.5MG 8.67k 8.06k 7.93k 5.73k 6.24k 7.85k
35MG 3.95k 3.57k 3.64k 3.16k 3.35k 3.73k

Source: Symphony Health Solutions 

[doogdilinger]

Awesome news...PAR finally launched the final 2 remaining additional strengths so more revenues coming. So next years FocalinXR revs for IPCI should hopefully come in around $5M minimum with PAR finally selling 8 strengths!